Cannabis Law Report

DECEMBER 3, 2021

We look forward to sharing clinical trial data supporting the potential of ganaxolone to treat a range of seizure disorders as well as research data highlighting the impact that seizures can have on developmental progressions and quality of life in children with CDD.”. Chief Executive Officer of Marinus Pharmaceuticals. “We for placebo.

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Image by Pfüderi from Pixabay.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

MMJ Recs

MARCH 28, 2024

With evolving laws and regulations, finding the right MMJ doctor and understanding the appointment process are crucial steps. From researching qualified doctors to scheduling appointments and discussing treatment options, we provide practical insights and tips to help patients confidently navigate this journey.

Patients 52

Patients Treatment Research and Development Therapy 52

United Patients Group

OCTOBER 25, 2023

From understanding the legality of medical marijuana to its efficacy in treating various medical conditions, our guide will equip you with essential knowledge and insights on this increasingly popular treatment option. Virgin Islands permitting its use for certain medical conditions. What Conditions Can Medical Marijuana Treat?

Marijuana 91

Marijuana Patients Research and Development Edibles 91

Veriheal

DECEMBER 8, 2023

The new law officially kicks in today, December 7th. This crease in the law essentially acknowledges that while THC can indicate impairment, THC stored in the body long after consumption does not mean one is CURRENTLY impaired. The new law also has a number of other exceptions. to embrace recreational cannabis.

Recreational 104

Recreational Research and Development Epilepsy THC 104

The Cannigma

MARCH 14, 2023

Those who were already under close watch by law enforcement because of structural racism, as well as those who were responsible for the well being of others had to be very careful about how they were perceived by those in control of the laws. 1 Of course, this risk was more intense for some than for others.

Policy 96

Policy Research and Development Conditions Consumption 96

Cannabis Law Report

AUGUST 10, 2021

The UK is a significant country for us for many reasons, and we are proud to be able to offer a medicine, that has been developed and is manufactured here, to even more patients across the UK. GW’s development programme represents the only well-controlled clinical evaluation of a cannabinoid medication for patients with refractory epilepsy.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

The Joint Blog

JUNE 4, 2021

Those state laws allow medical marijuana to be used to treat ailments like Alzheimer’s, cancer, epilepsy, Crohn’s disease, seizures, hepatitis C and a host of others. The United States Food and Drug Administration (FDA) has only cannabis use to treat two rare and severe forms of epilepsy: Dravet syndrome and Lennox-Gastaut syndrome.

Conditions 32

Conditions Chronic Pain Marijuana Research and Development 32

SpeedWeed

AUGUST 9, 2021

The first supply of medical cannabis for pediatric patients with epilepsy at the Buenos Aires National Children’s Garrahan Hospital was finally delivered. The delivery was a long-awaited result of Law 27,350. The law was passed in 2017, but it wasn’t regulated until November of last year. It modified Law No. Shutterstock.

Epilepsy 52

Epilepsy Research and Development Medicine Patients 52

The Cannigma

JUNE 15, 2021

Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

MMJ Recs

MARCH 14, 2024

Qualifying Conditions for Medical Marijuana in West Virginia West Virginia’s medical marijuana program encompasses an extensive list of qualifying conditions, providing access to patients with various chronic or debilitating diseases.

Dispensary 52

Dispensary Programs Legalization Marijuana 52

United Patients Group

FEBRUARY 8, 2023

Opioids are also prescribed to treat pain and other medical conditions such as coughs, diarrhea and muscle spasms. Natural opioids include opium or poppy seeds; synthetic ones were first developed in 1950s by German chemist Paul Janssen, who went on to found Janssen Pharmaceutica NV (now part of Johnson & Johnson).

Chronic Pain 83

Chronic Pain Cannabinoids Research and Development Patients 83

Cannabis Law Report

JULY 25, 2022

This article will help you understand the laws in Pennsylvania. Medical marijuana is only legal for those who suffer from a qualifying medical condition. Some of the conditions that qualify for receiving medical marijuana treatment in Pennsylvania include, but are not limited to: Muscle spasticity. Anxiety disorders. HIV / AIDS.

Legalization 52

Legalization Marijuana Epilepsy Sativa 52

Cannabis Law Report

JANUARY 16, 2022

Sativex was developed by GW Pharmaceuticals, a maker of cannabinoid therapeutics based in Ireland. Some conditions for which cannabis-based treatment has been advocated include epilepsy, neuropathic pain and chronic widespread pain as well as appetite problems, nausea and vomiting and pain in cancer patients.

Research and Development 98

Research and Development Pharmaceutical Epilepsy Medicine 98

United Patients Group

FEBRUARY 2, 2023

The ECS has been studied for its role in many diseases including cancer , epilepsy, chronic pain and multiple sclerosis (MS). Other research suggests that extra-strength cannabis strains high in CBD may also help treat insomnia related specifically to post traumatic stress disorder (PTSD).

Blood Pressure 104

Blood Pressure Sleep Chronic Pain Digestion 104

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

Medical marijuana laws have changed dramatically across the country in recent years, and now cannabis pharmaceuticals appear to be the next big leap forward in cannabis law reform. The recent years have seen drastic marijuana law changes in several states. Cannabis Legalization Throughout The Country.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

The Joint Blog

JULY 4, 2023

While people may primarily use it to induce a psychoactive effect, modern research has revealed its well-known therapeutic benefits. Today, as laws around cannabis become more progressive and industry innovations make strides in every area, from medical application to recreational enjoyment, knowledge about cannabis is spreading fast.

Sleep 52

Sleep Research and Development Food Conditions 52

PrestoDoctor

OCTOBER 13, 2023

Marinol, also known as Dronabinol, is a medication used to treat a variety of conditions, including nausea and vomiting caused by chemotherapy, loss of appetite and weight loss in people with HIV/AIDS, as well as chronic pain. The dosage and treatment duration may vary depending on the patient’s specific condition and medical history.

THC 98

THC Chronic Pain Treatment Conditions 98

Cannabis Law Report

JANUARY 10, 2022

This high share is attributable to the rising adoption of THCV for various applications such as epilepsy, arthritis, metabolic disorders, neurological disorders, and pain management. In 2020, the others segment accounted for the highest share in the market, owing to the increasing utilization of minor cannabinoids for health conditions.

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

United Patients Group

APRIL 24, 2023

In addition, cannabis might also help improve heart health by reducing inflammation around vessels; this reduces the risk of developing atherosclerosis (the hardening of arteries) or plaque buildup inside them. Gastrointestinal Disorders Gastrointestinal disorders are some of the most common conditions that medical cannabis can help treat.

Blood Pressure 52

Blood Pressure Sleep Cannabinoids Research and Development 52

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

MMJ Recs

DECEMBER 22, 2023

Historically, marijuana was vilified and classified as a Schedule I controlled substance, which hindered both research and public acceptance. One of the key drivers of this shift is the increasing body of scientific research highlighting the medical properties of cannabinoids, the active compounds in marijuana.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Veriheal

MAY 31, 2022

With a worsening opioid situation and an emerging acceptance of medical cannabis, the Lone Star State has a unique opportunity to develop a successful medical marijuana (MMJ) program for its millions of residents battling chronic pain and numerous other conditions. Despite the law being expanded twice since then, glaring gaps remain.

Programs 52

Programs Chronic Pain Treatment Conditions 52

CannaMD

AUGUST 8, 2020

Researchers believe cannabis contains over 100 unique chemical compounds! government classified all cannabis varieties, including hemp, as Schedule I under the Controlled Substances Act (despite decades of agricultural research detailing its differences from marijuana). What makes CBD special? In 1970, the U.S. CBD & Epidiolex.

CBD 99

CBD DEA Research and Development Hemp 99

Cannabis Law Report

MAY 3, 2022

Delta 8 has been found to be a helpful supplement for several health conditions and is starting to be used more in a medical setting. While research into the use of cannabinoids is still relatively new, prior research from the 1990s showed that our bodies contain a signaling system that bonds well with THC.

Chronic Pain 52

Chronic Pain Research and Development THC Cannabinoids 52

Cannabis Law Report

JULY 6, 2021

Currently, therapies for common neurological disorders such as concussion, migraine and cluster headache, neuropathic pain syndromes, and chronic epilepsy have limitations, especially when these disorders are associated with chronic psychological challenges.

Therapy 66

Therapy Research and Development Treatment Patients 66

Cannabis Law Report

NOVEMBER 24, 2019

Recommendations for research. Severe treatment-resistant epilepsy. 1.4 Severe treatment-resistant epilepsy. NICE has made research recommendations on the use of cannabis-based medicinal products for severe treatment-resistant epilepsy. They should also have a special interest in the condition being treated [ 5 ].

Medicine 59

Medicine Chronic Pain Research and Development Treatment 59

Cannabis Law Report

DECEMBER 9, 2019

Although research on CBD is still in its infancy, to date there have been dozens of studies with more on the horizon. Why so little research? Up until December of 2015, regulatory limitations put in place by the FDA prohibited researchers from conducting CBD-related trials in the US. Anxiety and Inflammation Lead the Pack.

Pets 59

Pets CBD Research and Development Epilepsy 59

Cannabis Law Report

JANUARY 12, 2020

But in Thailand change is afoot, as authorities seek to develop a homegrown medical marijuana industry. It has approved use of cannabis extracts for treatment of a range of illnesses and conditions, including cancer, epilepsy, Alzheimer’s, Parkinson’s disease and anxiety. billion ($96 billion) by the end of 2025.

Research and Development 59

Research and Development Marijuana Agriculture Medicine 59

Cannabis Law Report

DECEMBER 28, 2021

The users of CBD products claim to have seen improvement in different medical conditions, including depression, chronic pain, insomnia, epilepsy, anxiety, etc., Moreover, the FDA has also allowed researchers to conduct CBD trials. So, there are huge developments after that. after its consumption.

CBD 52

CBD Clinical Trials Consumption Chronic Pain 52

Cannabis Law Report

APRIL 4, 2019

House of Hemp hope to build on existing medical research and further explore the potential of cannabis as a healing plant. A big part of the licensing process will be that it will enable cannabis researchers to take their work further and conclusively prove what medical benefits, if any, the plant yields.

Cultivation 40

Cultivation Research and Development Chronic Pain Data 40

Otherside Farms

JANUARY 17, 2020

The Food and Drug Administration allows the use of CBD to treat pain, anxiety, depression, nausea, and some types of epilepsy. CBD is therefore convenient to those that suffer nausea from chemotherapy treatment and other conditions. CBD can help in alleviating those conditions that prevent them from feeling hungry.

Food 52

Food Research and Development Seed-To-Sale Vaping 52

The Joint Blog

JANUARY 20, 2021

In recent years, as more research and studies have been undertaken on the subject of marijuana, a range of new benefits have been discovered. Anti-Nausea – Marijuana can help to reduce sensations of nausea, ideal for those who feel nauseous often due to health conditions or treatments. Cannabis and Benefits.

Marijuana 68

Marijuana Sleep Chronic Pain Research and Development 68

Cannabis Law Report

SEPTEMBER 22, 2021

Supera-CBD is MyMD’s pre-clinical patented synthetic cannabidiol (CBD) derivative that is being developed as a pharmaceutical drug to address anxiety, pain, and neurodegeneration. A vast majority of CBD developers are pursuing compounds targeted to CB2 that have minimal CB1 affinity. Watch how Supera-CBD works. “We Chris Chapman, M.D.,

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Cannabis Law Report

JANUARY 27, 2022

However, one possible pro of New York’s medical approach is the focus on research. A psilocybin research licensee could also contract with a university or hospital within the University of New York system and conduct joint research projects. Shared Traits of Each Approach. You can contact Brett Mulligan at ? info@gl-lg.com ?

Legalization 52

Legalization Research and Development Legislation Treatment 52

Cannabis Law Report

JANUARY 6, 2020

The ongoing studies and research that focuses on CBD provide a very clear picture of how this compound can provide some health benefits relating to seizures, cancer, anxiety, pain, and inflammation. CBD can help manage pain associated with conditions like: Arthritis. Inflammatory Conditions. taking a dose. hronic Pain.

Oil 59

Oil CBD Sleep Research and Development 59